Patent and Trademark Office July 20, 2017 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Grant of Interim Extension of the Term of U.S. Patent No. 7,179,464; Benralizumab
The United States Patent and Trademark Office has issued an order granting interim extension for a one-year interim extension of the term of U.S. Patent No. 7,179,464.